(Q77087670)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

title

Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

1 reference

1 reference

Betsy Abraham

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Yaela Baine

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Norbert De-Clercq

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Etienne Tordeur

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Pascal P Gerard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Patrick L Manouvriez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Dennis L Parenti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

63-73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

Antibody production in response to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Simultaneous vaccination against hepatitis A and B: results of a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Are booster immunisations needed for lifelong hepatitis B immunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Interference of Antibody Production to Hepatitis B Surface Antigen in a Combination Hepatitis A/Hepatitis B Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

The assessment of immunity against hepatitis B after vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Potential alterations in immunogenicity by combining or simultaneously administering vaccine components.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Immunogenicity of a heat-treated recombinant DNA hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Can monovalent hepatitis A and B vaccines be replaced by a combined hepatitis A/B vaccine during the primary immunization course?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

The first combined vaccine against hepatitis A and B: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Heat stability of a recombinant DNA hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900194-2

7 January 2021

10.1016/S0166-3542(01)00194-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11684316%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference